The three approved Motiva devices are designed for use in the company’s next-generation minimally invasive aesthetic procedures. Credit: Nazarenko LLC / Shutterstock.com.

Medical technology company Establishment Labs has received a CE mark for its minimally invasive surgical tools designed for use in aesthetic surgery procedures.

The approved surgical tools include the Motiva inflatable balloon, Motiva channel dissector, as well as Motiva injector.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

These devices were approved under the European Medical Device Regulation (MDR).

Establishment Labs founder and CEO Juan José Chacón-Quirós said: “The approval in Europe of our minimally invasive tools is an important step in the evolution of plastic surgery. Innovations that improve both the experience and outcome of a medical procedure can expand markets.

“This minimally invasive technology platform can help change perceptions and overcome reservations — opening aesthetics to the many women who would not consider a traditional surgery.”

See Also:

The three Motiva devices are intended for use in the company’s next-generation minimally invasive aesthetic procedures.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Furthermore, the company has fully complied with the requirements of the new European MDR by transitioning all existing Motiva implants, tools and quality management systems.

UK-based plastic surgeon and researcher Professor Marcos Sforza said: “Medicine is often advanced with the development of innovative technology platforms that enhance the skill of the practitioner.

“These tools provide new capabilities that allow procedures to be performed more safely and predictably, resulting in better outcomes for our patients.”

Establishment Labs offers a range of femtech solutions for breast aesthetics, reconstruction and health.

The company’s Motiva Flora tissue expander is claimed to be the world’s only regulatory-approved magnetic resonance imaging conditional expander with an integrated port.

It is designed to enhance outcomes in the breast reconstruction process after breast cancer.